Geneva, March 23 -- International Clinical Trials Registry received information related to the study (ChiCTR2600120067) titled 'Study on the Application of ¹8F-FCOB04, a MAO-B Targeted PET Imaging Agent, in Neurodegenerative Diseases' on March 9.

Study Type: Interventional study

Study Design: Non randomized control

Primary Sponsor: Peking Union Medical College Hospital

Condition: neurodegenerative diseases

Intervention: Patients with neurodegenerative diseases:Perform 18F-FCOB04 PET/CT or PET/MRI brain scan

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-03-09

Target Sample Size: Patients with neurodegenerative diseases:30;Healthy Subject:10;

Countries of Recruitment: China

To know more,...